or
forgot password
  • cancer clinical trials in san antonio, TX

  • A Registry of Sipuleucel-T Therapy in Men With Advanced Prostate Cancer
    Urology San Antonio Research
    San Antonio, Texas 78229
    Advanced Prostate Cancer, Prostatic Neoplasms
    Caspofungin Acetate or Fluconazole in Preventing Invasive Fungal Infections in Patients With Acute Myeloid Leukemia Who Are Undergoing Chemotherapy
    Methodist Children's Hospital of South Texas
    San Antonio, Texas 78229-3993
    Fungal Infection, Leukemia, Neutropenia
    Evaluation of Safety, Tolerability, PK & PD of Intravenous VX15/2503 in Patients With Advanced Solid Tumors
    South Texas Accelerated Research Therapeutics, Llc
    San Antonio, Texas 78229
    Solid Tumors
    Comparison of Pixantrone + Rituximab With Gemcitabine + Rituximab in Patients With Aggressive B-cell Non-Hodgkin Lymphoma or Follicular Grade 3 Lymphoma Who Have Relapsed After Therapy and Are Not Eligible for Stem Cell Transplant
    Cancer Care Centers of South Texas-HOAST
    San Antonio, Texas 78229
    Diffuse Large B-cell Lymphoma, de Novo DLBCL, DLBCL Transformed From Indolent Lymphoma, Follicular Grade 3 Lymphoma
    A Dose Escalation Study of OMP-18R5 in Subjects With Solid Tumors
    South Texas Accelerated Research Therapeutics
    San Antonio, Texas 78229
    Solid Tumors
    Patients Treated for SCID (1968-2010)
    Methodist Children's Hospital of South Texas/Texas Transplant Institute
    San Antonio, Texas 78229
    SCID, ADA-SCID, XSCID, Leaky SCID, Omenn Syndrome, Reticular Dysgenesis
    Higher Per Daily Treatment-Dose Radiation Therapy or Standard Per Daily Treatment Radiation Therapy in Treating Patients With Early-Stage Breast Cancer That Was Removed by Surgery
    University of Texas Health Science Center at San Antonio

    Trial Locations
    University of Texas Health Science Center at San Antonio
    Cancer Care Centers of South Texas- Northeast
    Breast Cancer
    Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Waldenstrom's Macroglobulinemia
    University of Texas Health Science Center, San Antonio
    San Antonio, Texas 78229
    B Cell Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Waldenstrom Macroglobulinemia
    PET-Directed Therapy in Treating Patients With Limited-Stage Diffuse Large B-Cell Lymphoma
    University of Texas Health Science Center at San Antonio

    Trial Locations
    University of Texas Health Science Center at San Antonio
    Cancer Therapy and Research Center
    University Hospital - San Antonio
    Lymphoma
    Bortezomib and Sorafenib Tosylate in Patients With Newly Diagnosed Acute Myeloid Leukemia With or Without Mutations
    Methodist Children's Hospital of South Texas
    San Antonio, Texas 78229-3993
    Adult Acute Erythroid Leukemia (M6), Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), Adult Acute Monoblastic Leukemia (M5a), Adult Acute Monocytic Leukemia (M5b), Adult Acute Myeloblastic Leukemia With Maturation (M2), Adult Acute Myeloblastic Leukemia Without Maturation (M1), Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities, Adult Acute Myeloid Leukemia With Del(5q), Adult Acute Myeloid Leukemia With Inv(16)(p13;q22), Adult Acute Myeloid Leukemia With t(16;16)(p13;q22), Adult Acute Myeloid Leukemia With t(8;21)(q22;q22), Adult Acute Myelomonocytic Leukemia (M4), Adult Pure Erythroid Leukemia (M6b), Childhood Acute Erythroleukemia (M6), Childhood Acute Megakaryocytic Leukemia (M7), Childhood Acute Minimally Differentiated Myeloid Leukemia (M0), Childhood Acute Monoblastic Leukemia (M5a), Childhood Acute Monocytic Leukemia (M5b), Childhood Acute Myeloblastic Leukemia With Maturation (M2), Childhood Acute Myeloblastic Leukemia Without Maturation (M1), Childhood Acute Myelomonocytic Leukemia (M4), Untreated Adult Acute Myeloid Leukemia, Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
    Intravenous Administration of RGI-2001 in Patient Undergoing Allogenic Hematopoietic Stem Cell Transplantation (AHSCT)
    Methodist Healthcare System
    San Antonio, Texas 78229
    Prevention of GvHD in Patients With Hematological Malignancies Undergoing AHSCT
    A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer
    South Texas Oncology and Hematology, PA South Tex Onc
    San Antonio, Texas 78258
    Solid Tumors and Advanced Endometrial Cancer, Endometrial Cancer, Second-line Treatment, VEGF
    A Safety and Efficacy Study of Uvadex and Extracorporeal Photopheresis (ECP) in Chronic Graft Versus Host Disease
    Methodist Healthcare System of San Antonio
    San Antonio, Texas 78229
    Chronic Graft Versus Host Disease
    Modafinil in Treating Children With Memory and Attention Problems Caused by Cancer Treatment for a Brain Tumor
    University of Texas Health Science Center at San Antonio
    San Antonio, Texas 78284-7811
    Brain and Central Nervous System Tumors, Cognitive/Functional Effects, Fatigue, Neurotoxicity, Psychosocial Effects of Cancer and Its Treatment
    MRD Testing Before and After Hematopoietic Cell Transplantation Transplantation for Pediatric Acute Myeloid Leukemia
    Methodist Children's Hospital of South Texas/Texas Institute of Medicine and Surgery
    San Antonio, Texas 78229
    Acute Myeloid Leukemia
    Veliparib With or Without Radiation Therapy, Carboplatin, and Paclitaxel in Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery
    University of Texas Health Science Center at San Antonio

    Trial Locations
    University of Texas Health Science Center at San Antonio
    Cancer Therapy and Research Center at The UT Health Science Center at San Antonio
    Audie L Murphy Veterans Affairs Hospital
    University Hospital
    Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer, Bronchoalveolar Cell Lung Cancer, Large Cell Lung Cancer, Squamous Cell Lung Cancer, Stage IIIA Non-small Cell Lung Cancer, Stage IIIB Non-small Cell Lung Cancer
    A Phase 1 Study of LY2835219 In Participants With Advanced Cancer
    For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician
    San Antonio, Texas 78229
    Advanced Cancer
    MLN8237 in Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma Treated With Rituximab & Vincristine
    University of Texas Health Science Center at San Antonio
    San Antonio, Texas 78284-7811
    Diffuse Large B-Cell Lymphoma, Transformed Follicular Lymphoma, Mantle Cell Lymphoma, Burkitt's Lymphoma
    Safety and Efficacy Study of TH-302 CNS Penetration in Recurrent High Grade Astrocytoma Following Bevacizumab
    Cancer Therapy & Research Center at UTHSCSA
    San Antonio, Texas 78229
    HIGH GRADE GLIOMA
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed High-Risk Acute Lymphoblastic Leukemia
    University of Texas Health Science Center at San Antonio

    Trial Locations
    University of Texas Health Science Center at San Antonio
    Methodist Children's Hospital of South Texas
    B-cell Adult Acute Lymphoblastic Leukemia, B-cell Childhood Acute Lymphoblastic Leukemia, Cognitive/Functional Effects, Neurotoxicity, Pain, Philadelphia Chromosome Positive Childhood Precursor Acute Lymphoblastic Leukemia, Therapy-related Toxicity, Untreated Adult Acute Lymphoblastic Leukemia, Untreated Childhood Acute Lymphoblastic Leukemia
    Open-label Study of the Safety and Activity of Oprozomib in Patients With Hematologic Malignancies
    South Texas Accelerated Research Therapeutics
    San Antonio, Texas 78229
    Multiple Myeloma, Waldenstrom Macroglobulinemia
    Study With SAR302503 in Patients With Polycythemia Vera or Essential Thrombocythemia
    Investigational Site Number 840001
    San Antonio, Texas 78229
    Hematopoietic Neoplasm
    Bioequivalence of 2 Formulations of TKI258 in Patients With Advanced Solid Tumors
    Cancer Therapy & Research Center / UT Health Science Center InstituteForDrugDevelopment(5)
    San Antonio, Texas 78229
    Advanced Solid Tumors, Excluding Breast Cancer
    A Trial of Preoperative MM-121 With Paclitaxel in HER2-negative Breast Cancer
    Cancer Care Centers of South Texas
    San Antonio, Texas 78229
    ER Positive, Her2 Negative Breast Cancer Patients, Triple Negative Breast Cancer Patients
    Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma
    South Texas Accelerated Research Therapeutics, LLC (START)
    San Antonio, Texas 78229
    Solid Tumors, Non-Hodgkin's Lymphoma, Multiple Myeloma
    Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer
    Urology San Antonio Research
    San Antonio, Texas 78229
    Prostatic Neoplasm, Prostate Cancer, Prostatic Adenocarcinoma
    Objective Assessment of Technical Skills in Cardiothoracic Surgery
    The University of Texas Health Science Center at San Antonio
    San Antonio, Texas 78229
    Other Surgical Procedures
    Timolol for the Prevention of Proliferation of Infantile Hemangioma (TiPPIH Trial)
    University of Texas Health Science Center at San Antonio
    San Antonio, Texas 78284-7811
    Infantile Hemangioma, Very Low Birth Weight Infants, Prematurity
    Eribulin in Combination With Capecitabine for Adjuvant Treatment in Estrogen Receptor-Positive Early Stage Breast Cancer
    Cancer Care Centers of South Texas
    San Antonio, Texas 78229
    Estrogen Receptor Positive Tumor, Breast Cancer
    SAR3419 in Acute Lymphoblastic Leukemia
    Investigational Site Number 840001
    San Antonio, Texas 78229
    Acute Lymphocytic Leukaemia
    Safety and Efficacy Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine Fibroids
    Site Reference ID/Investigator# 48145
    San Antonio, Texas 79229
    Heavy Uterine Bleeding, Uterine Fibroids
    Pharmacokinetics (PK) of TKI258 in Cancer Patients With Normal and Impaired Hepatic Function
    Cancer Therapy & Research Center / UT Health Science Center SC
    San Antonio, Texas 78229
    Solid Tumors, Hepatic Impairment
    Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile
    Cancer Care Centers of South Texas
    San Antonio, Texas 78229
    Multiple Myeloma
    A Dose Escalation Study of Iniparib as a Single Agent and in Combination in Solid Tumors
    Investigational Site Number 840006
    San Antonio, Texas 78229
    Neoplasm Malignant
    Study of Dalantercept in Patients With Squamous Cell Carcinoma of the Head and Neck
    Acceleron Investigative Site
    San Antonio, Texas
    Squamous Cell Carcinoma of the Head and Neck
    Sunitinib Malate in Treating Younger Patients With Recurrent, Refractory, or Progressive Malignant Glioma or Ependymoma
    University of Texas Health Science Center at San Antonio
    San Antonio, Texas 78284-7811
    Childhood Cerebral Astrocytoma/Malignant Glioma, Childhood High-grade Cerebellar Astrocytoma, Childhood High-grade Cerebral Astrocytoma, Childhood Infratentorial Ependymoma, Childhood Mixed Glioma, Childhood Oligodendroglioma, Childhood Supratentorial Ependymoma, Recurrent Childhood Cerebellar Astrocytoma, Recurrent Childhood Cerebral Astrocytoma, Recurrent Childhood Ependymoma, Recurrent Childhood Subependymal Giant Cell Astrocytoma
    An A/B Dose Escalation Study of AbGn-7 Alone and With FOLFOX7 Treatment in Patients With Advanced Solid Tumors
    The University of Texas Health Science Center-CTRC
    San Antonio, Texas 78229
    Solid Tumor of Epithelial Origin, Gastric Cancer
    Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma
    University of Texas Health Science Center at San Antonio

    Trial Locations
    University of Texas Health Science Center at San Antonio
    Audie L Murphy Veterans Affairs Hospital
    University Hospital
    Southwest Oncology Group
    Southwest Oncology Group (SWOG) Research Base
    Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Hepatosplenic T-cell Lymphoma, Peripheral T-cell Lymphoma, Recurrent Adult Non-Hodgkin Lymphoma, Recurrent Adult T-cell Leukemia/Lymphoma
    NBRST: Prospective Neo-adjuvant REGISTRY Trial
    Radiation Oncology of San Antonio
    San Antonio, Texas
    Breast Cancer
    Efficacy and Safety Study of NeuVax(TM)(Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence
    Clinical Trials of Texas, Inc
    San Antonio, Texas 78229
    HER2 Negative Breast Cancer
    Efficacy and Safety of GS-6624 With FOLFIRI as Second Line Treatment in Colorectal Adenocarcinoma
    South Texas Oncology and Hematology, PA
    San Antonio, Texas 78229
    Colorectal Cancer
    EP-100 Plus Paclitaxel Versus Paclitaxel Alone in Patients With Ovarian Cancer
    Investigational Site Number 840006
    San Antonio, Texas 78229
    Ovarian Cancer Recurrent
    The BEACON Study (Breast Cancer Outcomes With NKTR-102)
    Cancer Care Centers of South Texas
    San Antonio, Texas 78229
    Locally Recurrent Breast Cancer, Metastatic Breast Cancer
    Phase 3 Papulopustular Rosacea Study
    Progressive Clinical Research
    San Antonio, Texas 78229
    Papulopustular Rosacea (PPR)
    AMR-001 Versus Placebo Post ST Segment Elevation Myocardial Infarction
    Methodist Health Systems of San Antonio
    San Antonio, Texas 78229
    ST Segment Elevation Myocardial Infarction